Non-classical role of Galectin-3 in cancer progression: translocation to nucleus by carbohydrate-recognition independent manner

키워드

참고문헌 (109)

1. Dumic J, "Galectin-3 : an open-ended story", Biochim Biophys Acta, 1760, pp.616~635 (2006)
2. Leffler H, "Introduction to galectins", Glycoconj J, 19, pp.433~440 (2002)
3. Drickamer K, "Genomic analysis of C-type lectins", Biochem Soc Symp, 69, pp.59~72 (2002)
4. Liu FT, "Galectins as modulators of tumour progression", Nat Rev Cancer, 5, pp.29~41 (2005)
5. Fortuna-Costa A, "Extracellular galectin-3 in tumor progression and metastasis", Front Oncol, 4, pp.138~ (2014)
6. Hirabayashi J, "The family of metazoan metal-independent beta-galactoside-binding lectins : structure, function and molecular evolution", Glycobiology, 3, pp.297~304 (1993)
7. Johannes L, "Galectins at a glance", J Cell Sci, 131 (2018)
8. Argueso P, "Focus on molecules : galectin-3", Exp Eye Res, 92, pp.2~3 (2011)
9. Ruvolo PP, "Galectin 3 as a guardian of the tumor microenvironment", Biochim Biophys Acta, 1863, pp.427~437 (2016)
10. Kadrofske MM, "The human LGALS3(galectin-3)gene : determination of the gene structure and functional characterization of the promoter", Arch Biochem Biophys, 349, pp.7~20 (1998)
11. Wang L, "Molecular regulation of galectin-3 expression and therapeutic implication in cancer progression", Biomed Pharmacother, 78, pp.165~171 (2016)
12. Krzeslak A, "Galectin-3 as a multifunctional protein", Cell Mol Biol Lett, 9, pp.305~328 (2004)
13. Raimond J, "Mapping of the galectin-3 gene(LGALS3)to human chromosome 14 at region 14q21-22", Mamm Genome, 8, pp.706~707 (1997)
14. Hughes RC, "Secretion of the galectin family of mammalian carbohydrate-binding proteins", Biochim Biophys Acta, 1473, pp.172~185 (1999)
15. Yu F, "Galectin-3translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation", J Biol Chem, 277, pp.15819~15827 (2002)
16. van den Brule F, "Expression of galectins in cancer : a critical review", Glycoconj J, 19, pp.537~542 (2002)
17. Ochieng J, "Extracellular functions of galectin-3", Glycoconj J, 19, pp.527~535 (2002)
18. Inohara H, "Identification of human melanoma cellular and secreted ligands for galectin-3", Biochem Biophys Res Commun, 201, pp.1366~1375 (1994)
19. Yang RY, "Galectins : structure, function and therapeutic potential", Expert Rev Mol Med, 10, pp.e17~ (2008)
20. Haudek KC, "Dynamics of galectin-3 in the nucleus and cytoplasm", Biochim Biophys Acta, 1800, pp.181~189 (2010)
21. Thijssen VL, "Galectin expression in cancer diagnosis and prognosis : A systematic review", Biochim Biophys Acta, 1855, pp.235~247 (2015)
22. Ebrahim AH, "Galectins in cancer : carcinogenesis, diagnosis and therapy", Ann Transl Med, 2, pp.88~ (2014)
23. Takenaka Y, "Malignant transformation of thyroid follicular cells by galectin-3", Cancer Lett, 195, pp.111~119 (2003)
24. Markowska AI, "Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells", J Biol Chem, 286, pp.29913~29921 (2011)
25. Hughes RC, "Galectins as modulators of cell adhesion", Biochimie, 83, pp.667~676 (2001)
26. Kim HR, "Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells", Cancer Res, 59, pp.4148~4154 (1999)
27. Zhao Q, "Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis", Mol Cancer, 9, pp.154~ (2010)
28. Yang RY, "Expression of galectin-3 modulates T-cell growth and apoptosis", Proc Natl Acad Sci U S A, 93, pp.6737~6742 (1996)
29. Harazono Y, "Galectin-3leads to attenuation of apoptosis through Bax heterodimerization in human thyroid carcinoma cells", Oncotarget, 5, pp.9992~10001 (2014)
30. Nakahara S, "On the role of galectin-3 in cancer apoptosis", Apoptosis, 10, pp.267~275 (2005)
31. Nangia-Makker P, "Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancer", Int J Cancer, 127, pp.2530~2541 (2010)
32. Wang LF, "The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation", Oncogene, 37, pp.601~615 (2018)
33. Nangia-Makker P, "Galectin-3 induces endothelial cell morphogenesis and angiogenesis", Am J Pathol, 156, pp.899~909 (2000)
34. Kim SJ, "Galectin-3 facilitates cell motility in gastric cancer by up-regulating protease-activated receptor-1(PAR-1)and matrix metalloproteinase-1(MMP-1)", PLoS One, 6, pp.e25103~ (2011)
35. Kim SJ, "Galectin-3increases gastric cancer cell motility by up-regulating fascin-1 expression", Gastroenterology, 138, pp.1035~1045 (2010)
36. Kang HG, "Galectin-3 interacts with C", EBPbeta and upregulates hyaluronan-mediated motility receptor expression in gastric cancer, 2020, pp.18, 403~413
37. Dong R, "Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy(Review)", Int J Mol Med, 41, pp.599~614 (2018)
38. Califice S, "Galectin-3 and cancer(Review)", Int J Oncol, 25, pp.983~992 (2004)
39. Baldus SE, "Increased galectin-3 expression in gastric cancer : correlations with histopathological subtypes, galactosylated antigens and tumor cell proliferation", Tumour Biol, 21, pp.258~266 (2000)
40. Volante M, "Diagnostic role of galectin-3 in follicular thyroid tumors", Virchows Arch, 444, pp.309~312 (2004)
41. Gudowska M, "Galectin-3 Concentration in Liver Diseases", Ann Clin Lab Sci, 45, pp.669~673 (2015)
42. Inufusa H, "Role of galectin-3 in adenocarcinoma liver metastasis", Int J Oncol, 19, pp.913~919 (2001)
43. Honjo Y, "Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma", Clin Cancer Res, 6, pp.4635~4640 (2000)
44. Shimamura T, "Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas", Clin Cancer Res, 8, pp.2570~2575 (2002)
45. Sciacchitano S, "Galectin-3 : One Molecule for an Alphabet of Diseases, from A to Z", Int J Mol Sci, 19, pp.pii: E379~ (2018)
46. Castronovo V, "Decreased expression of galectin-3 is associated with progression of human breast cancer", J Pathol, 179, pp.43~48 (1996)
47. Honjo Y, "Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells", Clin Cancer Res, 7, pp.661~668 (2001)
48. Pacis RA, "Decreased galectin-3 expression in prostate cancer", Prostate, 44, pp.118~123 (2000)
49. Brustmann H, "Galectin-3expression in normal, hyperplastic, and neoplastic endometrial tissues", Pathol Res Pract, 199, pp.151~158 (2003)
50. Shimonishi T, "Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma", Hum Pathol, 32, pp.302~310 (2001)
51. van den Brule FA, "Alteration of the cytoplasmic", nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression, 2000, pp.89, 361~367
52. Jin L, "Galectin-3 Expression in Functioning and Silent ACTH-Producing Adenomas", Endocr Pathol, 16, pp.107~114 (2005)
53. Shimura T, "Implication of galectin-3 in Wnt signaling", Cancer Res, 65, pp.3535~3537 (2005)
54. Itoh K, "Nuclear localization is required for Dishevelled function in Wnt", beta-catenin signaling, 2005, pp.4, 3~
55. Kang HG, "Galectin-3supports stemness in ovarian cancer stem cells by activation of the Notch1 intracellular domain", Oncotarget, 7, pp.68229~68241 (2016)
56. Pikarsky E, "NF-kappaB functions as a tumour promoter in inflammation-associated cancer", Nature, 431, pp.461~466 (2004)
57. Davidson PJ, "Shuttling of galectin-3between the nucleus and cytoplasm", Glycobiology, 12, pp.329~337 (2002)
58. Arnoys EJ, "Nucleocytoplasmic shuttling of galectin-3", Methods Mol Biol, 1207, pp.465~483 (2015)
59. Nakahara S, "Characterization of the nuclear import pathways of galectin-3", Cancer Res, 66, pp.9995~10006 (2006)
60. Nakahara S, "Importin-mediated nuclear translocation of galectin-3", J Biol Chem, 281, pp.39649~39659 (2006)
61. Davidson PJ, "Transport of galectin-3 between the nucleus and cytoplasm. I. Conditions and signals for nuclear import", Glycobiology, 16, pp.602~611 (2006)
62. Li SY, "Transport of galectin-3 between the nucleus and cytoplasm. II. Identification of the signal for nuclear export", Glycobiology, 16, pp.612~622 (2006)
63. Kim SJ, "Galectin-3germline variant at position 191 enhances nuclear accumulation and activation of beta-catenin in gastric cancer", Clin Exp Metastasis, 28, pp.743~750 (2011)
64. Balan V, "Racial disparity in breast cancer and functional germ line mutation in galectin-3(rs4644) : a pilot study", Cancer Res, 68, pp.10045~10050 (2008)
65. Dagher SF, "Identification of galectin-3 as a factor in pre-mRNA splicing", Proc Natl Acad Sci U S A, 92, pp.1213~1217 (1995)
66. Inohara H, "Galectin-3stimulates cell proliferation", Exp Cell Res, 245, pp.294~302 (1998)
67. Bresalier RS, "Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3", Gastroenterology, 115, pp.287~296 (1998)
68. Takenaka Y, "Galectin-3and metastasis", Glycoconj J, 19, pp.543~549 (2004)
69. Raz A, "Evidence for the role of 34-kDa galactoside-binding lectin in transformation and metastasis", Int J Cancer, 46, pp.871~877 (1990)
70. Hood JD, "Role of integrins in cell invasion and migration", Nat Rev Cancer, 2, pp.91~100 (2002)
71. Yoder BJ, "The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course", Clin Cancer Res, 11, pp.186~192 (2005)
72. Kureishy N, "Fascins, and their roles in cell structure and function", Bioessays, 24, pp.350~361 (2002)
73. Hashimoto Y, "Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma", Clin Cancer Res, 11, pp.2597~2605 (2005)
74. Jawhari AU, "Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro", Am J Pathol, 162, pp.69~80 (2003)
75. Grothey A, "C-erbB-2", HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines, 2000, pp.19, 4864~4875
76. Hashimoto Y, "The prognostic relevance of fascin expression in human gastric carcinoma", Oncology, 67, pp.262~270 (2004)
77. Yamashiro S, "Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells", Mol Biol Cell, 9, pp.993~1006 (1998)
78. Shonukan O, "Neurotrophin-induced melanoma cell migration is mediated through the actin-bundling protein fascin", Oncogene, 22, pp.3616~3623 (2003)
79. Shimura T, "Galectin-3, a novel binding partner of beta-catenin", Cancer Res, 64, pp.6363~6367 (2004)
80. Macfarlane SR, "Proteinase-activated receptors", Pharmacol Rev, 53, pp.245~282 (2001)
81. Tellez C, "Role and regulation of the thrombin receptor(PAR-1)in human melanoma", Oncogene, 22, pp.3130~3137 (2003)
82. Arora P, "Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer", J Cell Sci, 120, pp.921~928 (2007)
83. Pei D, "Matrix metalloproteinases target proteaseactivated receptors on the tumor cell surface", Cancer Cell, 7, pp.207~208 (2005)
84. Blackburn JS, "A matrix metalloproteinase-1", protease activated receptor-1signaling axis promotes melanoma invasion and metastasis, 2009, pp.28, 4237~4248
85. Song S, "Galectin-3 modulates MUC2 mucin expression in human colon cancer cells at the level of transcription via AP-1 activation", Gastroenterology, 129, pp.1581~1591 (2005)
86. Wilson NH, "Neogenin : one receptor, many functions", Int J Biochem Cell Biol, 39, pp.874~878 (2007)
87. Kim SJ, "Up-regulation of neogenin-1 increases cell proliferation and motility in gastric cancer", Oncotarget, 5, pp.3386~3398 (2014)
88. Li J, "Phosphorylation of BACH1 switches its function from transcription factor to mitotic chromosome regulator and promotes its interaction with HMMR", Biochem J, 475, pp.981~1002 (2018)
89. Yeh MH, "Extracellular Matrix-receptor Interaction Signaling Genes Associated with Inferior Breast Cancer Survival", Anticancer Res, 38, pp.4593~4605 (2018)
90. Casini P, "RHAMM mRNA expression in proliferating and migrating cells of the developing central nervous system", Gene Expr Patterns, 10, pp.93~97 (2010)
91. Bahrami SB, "Receptor for hyaluronan mediated motility(RHAMM", HMMR)is a novel target for promoting subcutaneous adipogenesis, 2017, pp.9, 223~237
92. Connell M, "HMMR acts in the PLK1-dependent spindle positioning pathway and supports neural development", Elife, 6, pp.e28672~ (2017)
93. Silverman AM, "A galectin-3-dependent pathway upregulates interleukin-6 in the microenvironment of human neuroblastoma", Cancer Res, 72, pp.2228~2238 (2012)
94. Regalo G, "C", EBPbeta regulates homeostatic and oncogenic gastric cell proliferation, 2016, pp.94, 1385~1395
95. Vaught JB, "Biorepository and biospecimen science : a new focus for CEBP", Cancer Epidemiol Biomarkers Prev, 15, pp.1572~1573 (2006)
96. Kuilman T, "The essence of senescence", Genes Dev, 24, pp.2463~2479 (2010)
97. Kim SJ, "Ablation of galectin-3 induces p27(KIP1)-dependent premature senescence without oncogenic stress", Cell Death Differ, 21, pp.1769~1779 (2014)
98. La SH, "Ablation of human telomerase reverse transcriptase(hTERT)induces cellular senescence in gastric cancer through a galectin-3 dependent mechanism", Oncotarget, 7, pp.57117~57130 (2016)
99. Nangia-Makker P, "Galectin-3and cancer stemness", Glycobiology, 28, pp.172~181 (2018)
100. Ma J, "MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Kruppel-like factor 4", Cancer Lett, 355, pp.85~95 (2014)
101. Seguin L, "An integrin beta(3)-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition", Nat Cell Biol, 16, pp.457~468 (2014)
102. Shekhar MP, "Alterations in galectin-3 expression and distribution correlate with breast cancer progression : functional analysis of galectin-3 in breast epithelial-endothelial interactions", Am J Pathol, 165, pp.1931~1941 (2004)
103. El Gendy H, "Galectin 3 for the diagnosis of bladder cancer", Arab J Urol, 12, pp.178~181 (2014)
104. Yoshii T, "Galectin-3maintains the transformed phenotype of thyroid papillary carcinoma cells", Int J Oncol, 18, pp.787~792 (2001)
105. Nangia-Makker P, "Regulation of tumor progression by extracellular galectin-3", Cancer Microenviron, 1, pp.43~51 (2008)
106. Chen WS, "Galectin-3 Inhibition by a Small-Molecule Inhibitor Reduces Both Pathological Corneal Neovascularization and Fibrosis", Invest. Ophthalmol Vis Sci, 58, pp.9~20 (2017)
107. Glinskii OV, "Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic", galectin-3 inhibitor lactulose-L-leucine, 2012, pp.14, 65~73
108. Campo VL, "Synthetic glycoconjugates inhibitors of tumor-related galectin-3 : an update", Glycoconj J, 33, pp.853~876 (2016)
109. Zetterberg FR, "Monosaccharide Derivatives with Low-Nanomolar Lectin Affinity and High Selectivity Based on Combined Fluorine-Amide, Phenyl-Arginine, Sulfur-pi, and Halogen Bond Interactions", Chem Med Chem, 13, pp.133~137 (2018)